Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County.

Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Care Res (Hoboken). 2018 Jul 25. doi: 10.1002/acr.23707. [Epub ahead of print]

PMID:
30044541
2.

Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Hardt U, Larsson A, Gunnarsson I, Clancy RM, Petri M, Buyon JP, Silverman GJ, Svenungsson E, Grönwall C.

Arthritis Res Ther. 2018 Feb 26;20(1):36. doi: 10.1186/s13075-018-1530-2.

3.

Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE.

Ann Rheum Dis. 2018 Apr;77(4):549-555. doi: 10.1136/annrheumdis-2017-212224. Epub 2018 Jan 25.

PMID:
29371202
4.

Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events.

Smilowitz NR, Katz G, Buyon JP, Clancy RM, Berger JS.

J Thromb Thrombolysis. 2018 Jan;45(1):13-17. doi: 10.1007/s11239-017-1591-0.

PMID:
29230625
5.

Association of Natural Killer Cell Ligand Polymorphism HLA-C Asn80Lys With the Development of Anti-SSA/Ro-Associated Congenital Heart Block.

Ainsworth HC, Marion MC, Bertero T, Brucato A, Cimaz R, Costedoat-Chalumeau N, Fredi M, Gaffney P, Kelly J, Levesque K, Maltret A, Morel N, Ramoni V, Ruffatti A, Langefeld CD, Buyon JP, Clancy RM.

Arthritis Rheumatol. 2017 Nov;69(11):2170-2174. doi: 10.1002/art.40228. Epub 2017 Oct 17.

PMID:
29045069
6.

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program.

Izmirly PM, Wan I, Sahl S, Buyon JP, Belmont HM, Salmon JE, Askanase A, Bathon JM, Geraldino-Pardilla L, Ali Y, Ginzler EM, Putterman C, Gordon C, Helmick CG, Parton H.

Arthritis Rheumatol. 2017 Oct;69(10):2006-2017. doi: 10.1002/art.40192. Epub 2017 Sep 10.

PMID:
28891252
7.

Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients.

Blazer A, Wang B, Simpson D, Kirchhoff T, Heffron S, Clancy RM, Heguy A, Ray K, Snuderl M, Buyon JP.

PLoS One. 2017 Aug 29;12(8):e0182483. doi: 10.1371/journal.pone.0182483. eCollection 2017.

8.

Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

Izmirly PM, Halushka MK, Rosenberg AZ, Whelton S, Rais-Bahrami K, Nath DS, Parton H, Clancy RM, Rasmussen S, Saxena A, Buyon JP.

Autoimmun Rev. 2017 Sep;16(9):980-983. doi: 10.1016/j.autrev.2017.07.013. Epub 2017 Jul 12. Review.

PMID:
28709760
9.

Cardiac fibroblast transcriptome analyses support a role for interferogenic, profibrotic, and inflammatory genes in anti-SSA/Ro-associated congenital heart block.

Clancy RM, Markham AJ, Jackson T, Rasmussen SE, Blumenberg M, Buyon JP.

Am J Physiol Heart Circ Physiol. 2017 Sep 1;313(3):H631-H640. doi: 10.1152/ajpheart.00256.2017. Epub 2017 Jun 16.

PMID:
28626076
10.

No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

Friedman D, Lovig L, Halushka M, Clancy RM, Izmirly PM, Buyon JP.

Clin Exp Rheumatol. 2017 Sep-Oct;35(5):857-859. Epub 2017 Jun 6.

11.

Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus.

Izmirly P, Saxena A, Buyon JP.

Curr Opin Rheumatol. 2017 Sep;29(5):467-472. doi: 10.1097/BOR.0000000000000414. Review.

PMID:
28520682
12.

Contribution of Socioeconomic Status to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes Among Women With Systemic Lupus Erythematosus.

Kaplowitz ET, Ferguson S, Guerra M, Laskin CA, Buyon JP, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Merrill JT, Katz P, Salmon JE.

Arthritis Care Res (Hoboken). 2018 Feb;70(2):230-235. doi: 10.1002/acr.23263. Epub 2017 Dec 29.

PMID:
28480528
13.

Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.

Der E, Ranabothu S, Suryawanshi H, Akat KM, Clancy R, Morozov P, Kustagi M, Czuppa M, Izmirly P, Belmont HM, Wang T, Jordan N, Bornkamp N, Nwaukoni J, Martinez J, Goilav B, Buyon JP, Tuschl T, Putterman C.

JCI Insight. 2017 May 4;2(9). pii: 93009. doi: 10.1172/jci.insight.93009. [Epub ahead of print]

14.

Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946. doi: 10.2215/CJN.11431116. Epub 2017 Apr 11.

15.

Activated Platelets Induce Endothelial Cell Activation via an Interleukin-1β Pathway in Systemic Lupus Erythematosus.

Nhek S, Clancy R, Lee KA, Allen NM, Barrett TJ, Marcantoni E, Nwaukoni J, Rasmussen S, Rubin M, Newman JD, Buyon JP, Berger JS.

Arterioscler Thromb Vasc Biol. 2017 Apr;37(4):707-716. doi: 10.1161/ATVBAHA.116.308126. Epub 2017 Feb 2.

16.

Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.

Reed JH, Gorny MK, Li L, Cardozo T, Buyon JP, Clancy RM.

J Autoimmun. 2017 May;79:99-104. doi: 10.1016/j.jaut.2017.01.004. Epub 2017 Jan 22.

17.

Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity.

Sisirak V, Sally B, D'Agati V, Martinez-Ortiz W, Özçakar ZB, David J, Rashidfarrokhi A, Yeste A, Panea C, Chida AS, Bogunovic M, Ivanov II, Quintana FJ, Sanz I, Elkon KB, Tekin M, Yalçınkaya F, Cardozo TJ, Clancy RM, Buyon JP, Reizis B.

Cell. 2016 Jun 30;166(1):88-101. doi: 10.1016/j.cell.2016.05.034. Epub 2016 Jun 9.

18.

Modulation of natural IgM autoantibodies to oxidative stress-related neo-epitopes on apoptotic cells in newborns of mothers with anti-Ro autoimmunity.

Grönwall C, Clancy RM, Getu L, Lloyd KA, Siegel DL, Reed JH, Buyon JP, Silverman GJ.

J Autoimmun. 2016 Sep;73:30-41. doi: 10.1016/j.jaut.2016.05.014. Epub 2016 Jun 8.

19.

Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.

Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE.

Arthritis Rheumatol. 2016 Aug;68(8):1964-9. doi: 10.1002/art.39668.

20.

Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system.

Izmirly PM, Saxena A, Sahl SK, Shah U, Friedman DM, Kim MY, Buyon JP.

Ann Rheum Dis. 2016 Jun;75(6):1161-5. doi: 10.1136/annrheumdis-2015-208311. Epub 2015 Dec 1.

21.

Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results.

Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE.

Lupus Sci Med. 2016 Jan 12;3(1):e000131. doi: 10.1136/lupus-2015-000131. eCollection 2016.

22.

Predictors of Pregnancy Outcomes in Patients With Lupus.

Buyon JP, Kim MY, Salmon JE.

Ann Intern Med. 2016 Jan 19;164(2):131. doi: 10.7326/L15-0500. No abstract available.

PMID:
26784479
23.

Autoimmune congenital heart block: complex and unusual situations.

Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA.

Lupus. 2016 Feb;25(2):116-28. doi: 10.1177/0961203315624024. Review.

PMID:
26762645
24.

Endosomal Toll-like receptors in clinically overt and silent autoimmunity.

Clancy RM, Markham AJ, Buyon JP.

Immunol Rev. 2016 Jan;269(1):76-84. doi: 10.1111/imr.12383. Review.

25.

Targeting downstream transcription factors and epigenetic modifications following Toll-like receptor 7/8 ligation to forestall tissue injury in anti-Ro60 associated heart block.

Clancy RM, Markham AJ, Reed JH, Blumenberg M, Halushka MK, Buyon JP.

J Autoimmun. 2016 Feb;67:36-45. doi: 10.1016/j.jaut.2015.09.003. Epub 2015 Oct 1.

26.

Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.

Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE.

Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14. doi: 10.1016/j.ajog.2015.09.066. Epub 2015 Sep 29.

27.

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

Saxena A, Izmirly PM, Han SW, Briassouli P, Rivera TL, Zhong H, Friedman DM, Clancy RM, Buyon JP.

J Am Coll Cardiol. 2015 Aug 25;66(8):930-9. doi: 10.1016/j.jacc.2015.06.1088. Erratum in: J Am Coll Cardiol. 2015 Oct 20;66(16):1849.

28.

Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controlled study.

Merrill JT, van Vollenhoven RF, Buyon JP, Furie RA, Stohl W, Morgan-Cox M, Dickson C, Anderson PW, Lee C, Berclaz PY, Dörner T.

Ann Rheum Dis. 2016 Feb;75(2):332-40. doi: 10.1136/annrheumdis-2015-207654. Epub 2015 Aug 20.

PMID:
26293163
29.

A highlight from the LUPUS 2014 meeting: eight great ideas.

Buyon JP, Cohen P, Merrill JT, Gilkeson G, Kaplan M, James J, McCune WJ, Bernatsky S, Elkon K.

Lupus Sci Med. 2015 Jun 30;2(1):e000087. doi: 10.1136/lupus-2015-000087. eCollection 2015. Review.

30.

Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.

Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE.

Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235.

31.

Reactivity to the p305 Epitope of the α1G T-Type Calcium Channel and Autoimmune-Associated Congenital Heart Block.

Markham AJ, Rasmussen SE, Salmon JE, Martinez-Ortiz W, Cardozo TJ, Clancy RM, Buyon JP.

J Am Heart Assoc. 2015 May 20;4(5). pii: e001836. doi: 10.1161/JAHA.115.001836.

32.

The clinical spectrum of autoimmune congenital heart block.

Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA.

Nat Rev Rheumatol. 2015 May;11(5):301-12. doi: 10.1038/nrrheum.2015.29. Epub 2015 Mar 24. Review.

33.

A 2014 update on the management of patients with systemic lupus erythematosus.

Merrill JT, Buyon JP, Utset T.

Semin Arthritis Rheum. 2014 Oct;44(2):e1-2. doi: 10.1016/j.semarthrit.2014.09.013. Epub 2014 Sep 30. Review.

PMID:
25437901
34.

Anti-C1q antibodies in systemic lupus erythematosus.

Orbai AM, Truedsson L, Sturfelt G, Nived O, Fang H, Alarcón GS, Gordon C, Merrill J, Fortin PR, Bruce IN, Isenberg DA, Wallace DJ, Ramsey-Goldman R, Bae SC, Hanly JG, Sanchez-Guerrero J, Clarke AE, Aranow CB, Manzi S, Urowitz MB, Gladman DD, Kalunian KC, Costner MI, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, Van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS, Petri M.

Lupus. 2015 Jan;24(1):42-9. doi: 10.1177/0961203314547791. Epub 2014 Aug 14.

35.

Prevention and treatment in utero of autoimmune-associated congenital heart block.

Saxena A, Izmirly PM, Mendez B, Buyon JP, Friedman DM.

Cardiol Rev. 2014 Nov-Dec;22(6):263-7. doi: 10.1097/CRD.0000000000000026. Review.

36.

Letter to the Editor in response to the article "Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials." by Gleicher N, Elkayam U, Autoimmun Rev. 2013 Sep;12(11):1039-45.

Costedoat-Chalumeau N, Izmirly P, Clancy R, Saxena A, Wahren-Herlenius M, Silverman E, Brucato A, Boutjdir M, Khamashta M, Llanos C, Pisoni CN, Friedman DM, Phoon CK, Buyon JP.

Autoimmun Rev. 2014 Jan;13(1):70-2. doi: 10.1016/j.autrev.2013.08.003. Epub 2013 Sep 2. No abstract available.

PMID:
24008147
37.

Ro60 requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus.

Reed JH, Sim S, Wolin SL, Clancy RM, Buyon JP.

J Immunol. 2013 Jul 1;191(1):110-6. doi: 10.4049/jimmunol.1202849. Epub 2013 May 22.

38.

A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies.

Briassouli P, Halushka MK, Reed JH, Molad Y, Fox-Talbot K, Buyon L, Guzman E, Ludomirsky A, Clancy RM, Buyon JP.

Rheumatology (Oxford). 2013 Aug;52(8):1448-53. doi: 10.1093/rheumatology/ket156. Epub 2013 Apr 18.

39.

Complement receptor 3 influences toll-like receptor 7/8-dependent inflammation: implications for autoimmune diseases characterized by antibody reactivity to ribonucleoproteins.

Reed JH, Jain M, Lee K, Kandimalla ER, Faridi MH, Buyon JP, Gupta V, Clancy RM.

J Biol Chem. 2013 Mar 29;288(13):9077-83. doi: 10.1074/jbc.M112.403303. Epub 2013 Feb 5.

40.

Reply: To PMID 23044629.

Lockshin MD, Cohn E, Aslam A, Buyon JP, Salmon JE.

Arthritis Rheum. 2013 Apr;65(4):1129-30. doi: 10.1002/art.37851. No abstract available.

41.

Sex ratios among children of lupus pregnancies.

Michael D Lockshin, Cohn E, Aslam A, Buyon JP, Salmon JE.

Arthritis Rheum. 2013 Jan;65(1):282. doi: 10.1002/art.37718. No abstract available.

42.

Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.

Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.

Arthritis Rheum. 2012 Dec;64(12):4040-7. doi: 10.1002/art.34669.

43.

Brief report: enrichment of associations in genes with fibrosis, apoptosis, and innate immunity functions with cardiac manifestations of neonatal lupus.

Ramos PS, Marion MC, Langefeld CD; International Consortium on Systemic Lupus Erythematosus Genetics, Buyon JP, Clancy RM.

Arthritis Rheum. 2012 Dec;64(12):4060-5. doi: 10.1002/art.34663.

44.

Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.

Izmirly PM, Buyon JP, Saxena A.

Curr Opin Rheumatol. 2012 Sep;24(5):466-72. doi: 10.1097/BOR.0b013e328356226b. Review.

45.
46.

Use of hydroxychloroquine in Japan.

Kishimoto M, Deshpande GA, Yokogawa N, Buyon JP, Okada M.

J Rheumatol. 2012 Jun;39(6):1296. doi: 10.3899/jrheum.111569. No abstract available.

PMID:
22661421
47.

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody-associated cardiac manifestations of neonatal lupus.

Izmirly PM, Costedoat-Chalumeau N, Pisoni CN, Khamashta MA, Kim MY, Saxena A, Friedman D, Llanos C, Piette JC, Buyon JP.

Circulation. 2012 Jul 3;126(1):76-82. doi: 10.1161/CIRCULATIONAHA.111.089268. Epub 2012 May 24.

48.

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, Sánchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS.

Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473.

49.

Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus.

Reed JH, Clancy RM, Lee KH, Saxena A, Izmirly PM, Buyon JP.

Arthritis Care Res (Hoboken). 2012 Sep;64(9):1373-81. doi: 10.1002/acr.21704.

50.

Finding the "PR-fect" solution: what is the best tool to measure fetal cardiac PR intervals for the detection and possible treatment of early conduction disease?

Phoon CK, Kim MY, Buyon JP, Friedman DM.

Congenit Heart Dis. 2012 Jul-Aug;7(4):349-60. doi: 10.1111/j.1747-0803.2012.00652.x. Epub 2012 Apr 12. Review.

Supplemental Content

Loading ...
Support Center